by Nathaniel Harding | Jan 23, 2024 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: Message from our Managing Partner Annual General Meeting 2023 Investment News: CorriXR Portco News: Glycologix Midcon Markup Podcast: New Episode with Blake Bixler Portco Job...
by Nathaniel Harding | Jan 22, 2024 | Media
FOR IMMEDIATE RELEASE Jan. 16, 2024 Contact: Anthony Triana atriana@saxum.com (Direct) 405.818.0791 Cortado Ventures Invests in CorriXR: A Groundbreaking Gene-Editing Company with Initial Focus on Oncology OKLAHOMA CITY – Cortado Ventures, a...
by Nathaniel Harding | Jan 19, 2024 | Media
Congratulations to our Managing Partner, Nathaniel Harding for earning another term of service for the Greater Oklahoma City Chamber board. Board members, in roles like this, play a pivotal part in shaping the direction and policies of the organization....
by Nathaniel Harding | Jan 4, 2024 | Blog
Preclinical biotechnology company initially focusing on therapeutic drug development to promote remyelination in Multiple Sclerosis OKLAHOMA CITY, Dec. 14, 2023 /PRNewswire/ — Cadenza Bio, Inc. (Cadenza), a privately-held biotechnology company focused on...
